MENU
+Compare
VIR
Stock ticker: NASDAQ
AS OF
Oct 8, 04:59 PM (EDT)
Price
$6.04
Change
+$0.39 (+6.89%)
Capitalization
786.27M

VIR Vir Biotechnology Forecast, Technical & Fundamental Analysis

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases... Show more

VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VIR with price predictions
Oct 07, 2025

VIR's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for VIR turned positive on September 19, 2025. Looking at past instances where VIR's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 26, 2025. You may want to consider a long position or call options on VIR as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

VIR moved above its 50-day moving average on September 18, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for VIR crossed bullishly above the 50-day moving average on September 09, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VIR advanced for three days, in of 258 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 49 cases where VIR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VIR broke above its upper Bollinger Band on September 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.830) is normal, around the industry mean (23.421). P/E Ratio (0.000) is within average values for comparable stocks, (54.441). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.237). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (54.054) is also within normal values, averaging (342.085).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. VIR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VIR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
VIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VIR is expected to report earnings to rise 5.09% to -84 cents per share on October 30

Vir Biotechnology VIR Stock Earnings Reports
Q3'25
Est.
$-0.84
Q2'25
Missed
by $0.10
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.11
Q3'24
Missed
by $0.51
The last earnings report on August 06 showed earnings per share of -80 cents, missing the estimate of -69 cents. With 2.14M shares outstanding, the current market capitalization sits at 786.27M.
A.I. Advisor
published General Information

General Information

a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1800 Owens Street
Phone
+1 415 906-4324
Employees
587
Web
https://www.vir.bio
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ENPIX41.32N/A
N/A
ProFunds UltraSector Energy Investor
FSENX61.90N/A
N/A
Fidelity Select Energy Portfolio
DNLVX21.78N/A
N/A
Dunham Large Cap Value N
ISTIX94.27N/A
N/A
Macquarie Science and Technology I
IHSFX24.28N/A
N/A
Hartford Small Company F

VIR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with SANA. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
+1.25%
SANA - VIR
63%
Loosely correlated
-0.96%
CPRX - VIR
47%
Loosely correlated
+0.43%
AXON - VIR
47%
Loosely correlated
-0.97%
NRIX - VIR
42%
Loosely correlated
-1.21%
RLAY - VIR
41%
Loosely correlated
+4.29%
More